Fabrication of cervical squamous cell carcinoma antigen immunosensor using graphene-polymer composites

An ultrasensitive electrochemical immunosensor was developed for detection of the cervical squamous cell carcinoma antigen (SCCA) biomarker using graphene-chitosan nanocomposites. Graphene oxide (GO) synthesized by a modified Hummer’s method was functionalized with chitosan biopolymer (CS) to produce CS-GO nanocomposites. Characterization by SEM, FTIR, Raman, XPS confirmed successful grafting of CS onto GO by electrostatic interactions. The CS-GO composite exhibited improved conductivity and biocompatibility. After optimizing the GO:CS ratio to 1:1, the nanocomposite was deposited on glassy carbon electrodes (GCE). Anti-SCCA antibodies were then immobilized covalently using pyrenebutyric acid crosslinker. The immunosensor fabrication was analyzed by EIS, CV, and DPV electrochemical techniques. The conditions including CS-GO ratio, antibody concentration, incubation time, pH, and voltage parameters were systematically optimized using orthogonal experimental design. Under optimal conditions, the immunosensor showed a linear detection range from 1 pg/mL to 100 ng/mL with a sensitivity of 196 μA/(ng/mL/cm2). The low limit of detection of 1 pg/mL was attributed to the high surface area and conductivity of the CS-GO transducer. Analysis of human serum samples spiked with SCCA demonstrated the reliability of the immunosensor for clinical applications. The graphene-nanocomposite electrochemical biosensing platform provides a rapid, low-cost, and ultrasensitive alternative to ELISA for SCCA detection in cervical cancer diagnostics.